Gastroesophageal Reflux Disease

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print

Volumn , Issue , 2010, Pages 705-726

  Richter, Joel E ^a   Friedenberg, Frank K ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956094566     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6189-2.00043-3     Document Type: Chapter

References (310)

1. American Lung Association Asthma Clinical Research Centers., Mastronarde JG., Anthonisen NR., et al. Efficacy of esomeprazole for treatment of poorly controlled asthma N Engl J Med 360 2009 1487-1499(Ref 288.)
2. Dent J Microscopic esophageal mucosal injury in nonerosive reflux disease Clin Gastroenterol Hepatol 5 2007 4-16(Ref 172.)
3. DeVault KR., Castell DO Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease Am J Gastroenterol 100 2005 190(Ref 171.)
4. Falk GW., Fennerty MB., Rothstein RI AGA Institute technical review on the use of endoscopic therapy for gastroesophageal reflux disease Gastroenterology 131 2006 1351-1366(Ref 284.)
5. Fass R Erosive esophagitis and non-erosive reflux disease. Comparison of epidemiologic, physiologic and therapeutic characteristics J Clin Gastroenterol 41 2007 131-137(Ref 200.)
6. Friedenberg FK., Xanthopoulos M., Foster GF., Richter JE The association between gastroesophageal reflux disease and obesity Am J Gastroenterol 103 2008 2111-2122(Ref 30.)
7. Gralnek IM., Dulai GS., Fennerty MB., Speigel BMR Esomeprazole versus other PPIs in erosive esophagitis: A meta-analysis of randomized clinical trials Clin Gastroenterol Hepatol 4 2006 1452-1458(Ref 244.)
8. Hirano I., Richter JE ACG practice guidelines: Esophageal reflux testing Am J Gastroenterol 102 2007 668-685(Ref 176.)
9. Kaltenback T., Crockett S., Gerson LB Are lifestyle measures effective in patients with gastroesophageal reflux disease? Am J Gastroenterol 101 2006 2128-2138(Ref 211.)
10. Mittal RK., Balaban DH The esophagogastric junction N Engl J Med 336 1997 924-932(Ref 47.)
11. Mittal RK., Holloway RH., Penagini R., et al. Transient lower esophageal sphincter relaxation Gastroenterology 109 1995 601-610(Ref 54.)
12. Moayyedi P., Talley N Gastroesophageal reflux disease Lancet 367 2006 2086-2100(Ref 240.)
13. Serag HB Time trends for gastroesophageal reflux disease: A systematic review Clin Gastroenterol Hepatol 2007 17-26(Ref 14.)
14. van Malenstein H., Farré R., Sifrim D Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease Am J Gastroenterol 103 4 2008 1021-1028(Ref 86.)
15. Watson DI Laparoscopic treatment of gastro-oesophageal reflux disease Best Pract Res Clin Gastroenterol 18 2004 19-35(Ref 265.)
16. A Gallup Organization National Survey Heartburn across America 1988 The Gallup Organization Princeton, NJ.
17. Locke GR., Talley NJ., Fett SL., et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota Gastroenterology 112 1997 1448.
18. Stanghellini V Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors. Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST) Scand J Gastroenterol 34 1999 20.
19. Spechler SJ Epidemiology and natural history of gastro-esophageal reflux disease Digestion 51 1992 24-29.
20. Johnson DA., Fennerty MB Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease Gastroenterology 126 2004 660-664.
21. Collen MJ., Abdulian JD., Chen YK Gastroesophageal disease in the elderly: More severe disease that requires aggressive therapy Am J Gastroenterol 90 1995 1053-1057.
22. El-Serag HB., Peterson NJ., Carter J., et al. Gastroesophageal reflux among different ethnic groups in the United States Gastroenterology 126 2004 1692-1699.
23. Spechler SJ., Jain SK., Tendler DA., Parker RA Racial differences in the frequency of symptoms and complications of gastro-esophageal reflux disease Aliment Pharmacol Ther 16 2002 1795-1800.
24. Ho KY., Kang JY., Seow A Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms Am J Gastroenterol 93 1998 1816-1822.
25. Lim LG., Ho KY Gastroesophageal reflux disease at the turn of the millennium World J Gastroenterol 9 2003 2135-2136.
26. Kim N., Lee SW., Cho SI., et al. The prevalence of and risk factors for erosive esophagitis prospective study in Korea Aliment Pharmacol Ther 27 2008 173-185.
27. Goh KL., Chang CS., Fock KM., et al. Gastroesophageal reflux disease in Asia J Gastroenterol Hepatol 15 2000 230-238.
28. Richter JE., Falk GW., Vaezi MF Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad Am J Gastroenterol 93 1998 1800-1802.
29. Serag HB Time trends for gastroesophageal reflux disease: A systematic review Clin Gastroenterol Hepatol 2007 17-26.
30. El-Serag HB., Sonnenberg A Opposing time trends of peptic ulcer disease and reflux disease Gut 43 1998 327-333.
31. Mokdad A., Bowman B., Ford E., et al. The continuing epidemic of obesity and diabetes in the United States JAMA 286 2001 1195-1200.
32. Jacobson BC., Somers SC., Fuchs CS., et al. Body-mass index and symptoms of gastroesophageal reflux in women N Engl J Med 354 2006 2340-2348.
33. El-Serag HB., Graham DY., Satia JA., et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis Am J Gastroenterol 100 2005 1243-1250.
34. Murray L., Johnston B., Lane A., et al. Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter project Int J Epidemiol 32 2003 645-650.
35. Nocon M., Labenz J., Willich SN Lifestyle factors and symptoms of gastro-oesophageal reflux-A population-based study Aliment Pharmacol Ther 23 2006 169-174.
36. Nilsson M., Johnsen R., Ye W., et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms JAMA 290 2003 66-72.
37. Lagergren J., Bergstrom R., Nyren O No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study Gut 47 2000 26-29.
38. Corley DA., Kubo A., Zhao W Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms Gut 56 2007 756-762.
39. El-Serag HB., Ergun GA., Pandolfino J., et al. Obesity increases oesophageal acid exposure Gut 56 2007 749-755.
40. Stein DJ., El-Serag HB., Kuczynski J., et al. The association of body mass index with Barrett’s oesophagus Aliment Pharmacol Ther 22 2005 1005-1010.
41. El-Serag HB., Kvapil P., Hacken-Bitar J., et al. Abdominal obesity and the risk of Barrett’s esophagus Am J Gastroenterol 100 2005 2151-2156.
42. Freeman HJ Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment Best Pract Res Clin Gastroenterol 18 2004 1167-1175.
43. Lagergren J., Bergstrom R., Nyren O Association between body mass and adenocarcinoma of the esophagus and gastric cardia Ann Intern Med 130 1999 883-890.
44. Edelstein ZR., Farrow DC., Bronner MP., et al. Central adiposity and risk of Barrett’s esophagus Gastroenterology 133 2007 403-411.
45. Friedenberg FK., Xanthopoulos M., Foster GF., Richter JE The association between gastroesophageal reflux disease and obesity Am J Gastroenterol 103 2008 2111-2122.
46. Romero Y., Cameron AJ., Locke GR., et al. Familial aggregation of gastroesophageal reflux in patients with Barrett’s esophagus and esophageal adenocarcinoma Gastroenterology 113 1997 1149-1156.
47. Orenstein R., Shalaby TM., Barmada M., Whitcomb DC Genetics of gastroesophageal reflux disease: A review J Pediatr Gastroenterol Nutr 34 2002 506-510.
48. Cameron AJ., Lagergren J., Henriksson C., et al. Gastro-esophageal reflux disease in monozygotic and dizygotic twins Gastroenterology 122 2002 55-59.
49. Mohammed I., Cherhas LF., Riley SA., et al. Genetic influence in gastro-oesophageal reflux disease: A twin study Gut 52 2003 1085-1089.
50. Hu FZ., Preston RA., Post JC., et al. Mapping of a gene for severe pediatric gastroesophageal reflux disease to chromosome 13q14 JAMA 284 2000 325-334.
51. Orenstein SR., Shalaby TM., Finch R., et al. Autosomal dominant infantile gastro-esophageal reflux disease: Exclusion of a 13q14 locus in five well characterized families Am J Gastroenterol 97 2002 2725-2732.
52. Everhart JE., Ruhl CE Burden of digestive disease in the US Gastroenterology 136 2009 376-386.
53. Shaheen NJ., Hansen RA., Morgan DR., et al. The burden of gastrointestinal and liver disease 2006 Am J Gastroenterol 101 2006 2128-2128.
54. Willich SN., Nocon M., Kulig M., et al. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett’s mucosa Aliment Pharmacol Ther 23 2006 371-376.
55. Enck P., Dubois D., Marquis P Quality of life in patients with upper gastrointestinal symptoms: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST) Scand J Gastroenterol 34 1999 48-54.
56. Nojkov B., Rubinstein JH., Adlis SA., et al. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease Aliment Pharmacol Ther 27 2008 473-482.
57. Liebermann-Meffert D., Allgower M., Schmid P., Blum AL Muscular equivalent of the lower esophageal sphincter Gastroenterology 76 1979 31-38.
58. Sloan S., Rademaker AW., Kahrilas PJ Determinants of gastroesophageal junction incompetence: Hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med 117 1992 977-982.
59. Dodds WJ., Dent J., Hogan WJ., et al. Mechanisms of gastro-esophageal reflux in normal human subjects N Engl J Med 307 1982 1547-1552.
60. Casselbrant A, Edebo A, Wennerblom J. Actions by angiotensin II on esophageal contractility in humans.
61. Dodds WJ., Dent J., Hogan W., Arndorfer R Effect of atropine on esophageal motor function in humans Am J Physiol 241 1981 G290-G296.
62. Mittal RK., Balaban DH The esophagogastric junction N Engl J Med 336 1997 924-932.
63. Mittal RK., Rochester DF., McCallum RW Electrical and mechanical activity in the human lower esophageal sphincter during diaphragmatic contraction J Clin Invest 81 1988 1182-1195.
64. Thor KB., Hill RD., Mercer DD., Kozarek RD Reappraisal of the flap valve mechanism in the gastroesophageal junction: A study of a new valvuloplasty procedure in cadavers Acta Chir Scand 153 1987 25-28.
65. Holloway RH., Penagini R., Ireland AC Criteria for objective definition of transient lower esophageal sphincter relaxation Am J Physiol 268 1995 G128-G133.
66. Dent J., Holloway RH., Toouli J., Dodds WJ Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux Gut 29 1988 1020-1028.
67. Herwaarden MV., Samsom M., Smout AJP Excess gastro-esophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxation Gastroenterology 119 2000 1439-1446.
68. Mittal RK., McCallum RW Characteristics of transient lower esophageal sphincter relaxation in humans Am J Physiol 252 1987 G636.
69. Mittal RK., Holloway RH., Penagini R., et al. Transient lower esophageal sphincter relaxation Gastroenterology 109 1995 601-610.
70. Holloway RH., Kocyan P., Dent J Provocation of transient lower esophageal sphincter relaxation by meals in patients with symptomatic gastroesophageal reflux Dig Dis Sci 36 1991 1034-1039.
71. Holloway RH The anti-reflux barrier and mechanisms of gastro-oesophageal reflux Baillieres Clin Gastroenterol 14 2000 681.
72. Zagorodynuk VP., Chen BN., Brookers SJ Intraganglionic laminar endings are mechano-transduction sites of vagal tension receptors in the guinea pig stomach J Physiol 534 2001 255.
73. Mittal RK., Lange RC., McCallum RW Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia Gastroenterology 92 1987 130.
74. Pandofino JE., Shi G., Trueworthy B., Kahrilas PJ Esophagogastric junction opening during relaxation distinguishes non-hernia reflux patients, hernia patients and normal subjects Gastroenterology 125 2003 1018.
75. Salapatek AMF., Diamant NE Assessment of neural inhibition of the lower esophageal sphincter in cats with esophagitis Gastroenterology 104 1993 810.
76. Singh P., Adamopoulos A., Taylor RH., Colin-James DG Oesophageal motor function before and after healing of oesophagitis Gut 33 1992 1590.
77. Mattioli S., D’Ovidio F., Pilotti V., et al. Hiatus hernia and intrathoracic migration of the esophagogastric junction in gastroesophageal reflux disease Dig Dis Sci 48 2003 1823.
78. Koek GH., Sifrim D., Lerut T., et al. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett’s oesophagus Gut 57 2008 1056-1064.
79. Sontag SJ., Schnell TG., Miller TQ., et al. The importance of hiatal hernia in reflux esophagitis compared with lower esophageal sphincter pressure or smoking J Clin Gastroenterol 13 1991 628.
80. Kahrilas PJ., Lin S., Chen J., Manka M The effect of hiatus hernia on gastro-esophageal junction pressure Gut 44 1999 476.
81. Kahrilas PJ., Shi G., Manka M., Joehl RJ Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distension in reflux patients with hiatal hernia Gastroenterology 118 2000 688.
82. Paterson WG., Kolyn DM Esophageal shortening induced by short-term intraluminal acid perfusion: A cause for hiatus hernia? Gastroenterology 107 1994 1736.
83. Wilson LJ., Ma W., Hirschowitz BI Association of obesity with hiatus hernia and esophagitis Am J Gastroenterol 94 1999 262.
84. Smith AB., Dickerman RD., McGuire CS., et al. Pressure overload induced sliding hiatal hernia in power athletes J Clin Gastroenterol 28 1999 352.
85. Helm JF., Dodds WJ., Pek LR., et al. Effect of esophageal emptying and saliva on clearance of acid from the esophagus N Engl J Med 310 1984 284.
86. Kahrilas PJ., Dodds WJ., Hogan WJ., et al. Esophageal peristaltic dysfunction in peptic esophagitis Gastroenterology 91 1986 897.
87. Johnson LF., DeMeester TR Elevation of the head of the bed, bethanechol and antacid foam tablets on gastroesophageal reflux Dig Dis Sci 26 1976 673.
88. Helm JF., Dodds WJ., Hogan WJ., et al. Acid neutralizing capacity of human saliva Gastroenterology 83 1987 69.
89. Orr WC., Robinson MG., Johnson LF., et al. Acid clearance during sleep in the pathogenesis of reflux esophagitis Dig Dis Sci 26 1987 423.
90. Korstein MA., Rosman AS., Fishbein S., et al. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury Am J Med 90 1991 701.
91. Kahrilas PJ., Gupta RR The effect of cigarette smoking on salivation and esophageal acid clearance J Lab Clin Med 114 1989 431.
92. Helm JF., Dodds WJ., Ricdel DR., et al. Determinants of esophageal acid clearance in normal subjects Gastroenterology 86 1983 607.
93. Meyers RL., Orlando RC In vivo bicarbonate secretion by human esophagus Gastroenterology 103 1992 1174.
94. Brown CM., Snowdon CF., Slee B., et al. Effect of topical oesophageal acidification on human salivary and oesophageal alkali secretion Gut 36 1995 649.
95. Orlando RC Esophageal epithelial defenses against acid injury Am J Gastroenterol 89 1994 349.
96. Quigley EMM., Turnberg LA pH of the microclimate lining human gastric and duodenal mucosa in vivo: Studies in control subjects and in duodenal ulcer patients Gastroenterology 92 1987 1876.
97. Orlando RC., Lacey ER., Tobey NA., Cowart K Barriers to paracellular permeability in rabbit esophageal epithelium Gastroenterology 102 1992 910.
98. Tobey NA., Reddy SP., Khalbuss WE., et al. Na+ dependent and independent CL-/HCO-exchanges in cultured rabbit esophageal epithelial cells Gastroenterology 104 1993 185.
99. 3- transport systems Am J Physiol 263 1992 G407.
100. Majewski M., Jaworski T., Sarosiek I., et al. Significant enhancement of esophageal pre-epithelial defense by tegaserod: Implications for an esophagoprotective effect Clin Gastroenterol Hepatol 5 2007 430-438.
101. van Malenstein H., Farré R., Sifrim D Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease Am J Gastroenterol 103 2008 1021-1028.
102. Farré R., De Vos R., Geboes K., et al. Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces Gut 56 2007 1191-1197.
103. Calabrese C., Fabbri A., Bortolotti M., et al. Dilated intercellular spaces as a marker of oesophageal damage: Comparative results in gastro-oesophageal reflux disease with or without bile reflux Aliment Pharmacol Ther 18 2003 525.
104. Calabrese C., Bortolotti M., Fabbri A., Areni G Reversibility of GERD ultrastructural alteration and relief of symptoms after omeprazole treatment Am J Gastroenterol 100 2005 537.
105. Rodrigo J., Hernandez DJ., Vidol MA., Pedrosa JA Vegetative innervation of the esophagus-intraepithelial endings Acta Anat (Basel) 92 1975 242.
106. Hollwarth ME., Smith M., Kvietys PR., et al. Esophageal blood flow in the cat: Normal distribution and effects of acid perfusion Gastroenterology 90 1986 622.
107. Vieth M., Kulig M., Leodolter A., et al. Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus Aliment Pharmacol Ther 23 2006 313-319.
108. Orlando RC., Bryson JC., Powell DW Mechanisms of H+ injury in rabbit esophageal epithelium Am J Physiol 246 1984 G718.
109. Stein HJ., Barlow AP., DeMeester TR., Hinder RA Complications of gastroesophageal reflux disease Ann Surg 216 1992 35.
110. Gillen P., Keeling P., Byrne PJ., Hennessy TPJ Barrett’s esophagus: pH profile Br J Surg 74 1987 774.
111. Hirschowitz BI A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis Gastroenterology 101 1991 1149.
112. Fletcher J., Wirz A., Henry E., McColl KEL Studies of acid exposure immediately above the gastroesophageal squamocolumnar junction: Evidence of short segment reflux Gut 53 2004 168.
113. Mekapati J., Knight LC., Maurer AH., et al. Transsphincteric pH profile at the gastroesophageal junction Clin Gastroenterol Hepatol 6 2008 630-634.
114. Vicari J., Peek RM., Falk GW., et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastro-esophageal reflux disease Gastroenterology 115 1998 50.
115. Loffeld RJLF., Werdmuller BFM., Kusta JG., et al. Colonization with cagA-positive H. pylori strains is inversely associated with reflux esophagitis and Barrett’s esophagus Digestion 62 2000 95.
116. Feldman M., Cryer B., Lee E Effects of Helicobacter pylori gastritis on gastric secretion in normal human beings Am J Physiol 274 1998 G1011.
117. Labenz J., Malfertheiner P Hpylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor Gut 41 1997 277.
118. Labenz J., Blum AL., Bayerdorffer E., et al. Curing H. pylori infection in duodenal ulcer patients may provoke reflux esophagitis Gastroenterology 112 1997 1442.
119. Fallone CA., Barkun AN., Friedman G., et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 95 2000 914.
120. Lillemoe KD., Johnson LF., Harmon JW Alkaline esophagitis: A comparison of the ability of components of the gastroduodenal contents to injure the rabbit esophagus Gastroenterology 85 1983 621.
121. Attwood SEA., DeMeester TR., Bremner CG., et al. Alkaline gastroesophageal reflux: Implications in the development of complications in Barrett’s columnar-lined esophagus Surgery 106 1989 764.
122. Pellegrini CA., DeMeester TR., Wernly JA., et al. Alkaline gastroesophageal reflux Am J Surg 75 1978 177.
123. Bechi P., Pucciani F., Baldini F., et al. Long-term ambulatory enterogastric reflux monitoring: Validation of a new fiberoptic technique Dig Dis Sci 38 1993 1297.
124. Vaezi MF., Richter JE Role of acid and duodenogastro-esophageal reflux in gastroesophageal reflux disease Gastroenterology 111 1996 1192.
125. Champion G., Richter JE., Vaezi MF., et al. Duodenogastro-esophageal reflux: Relationship to pH and importance in Barrett’s esophagus Gastroenterology 107 1994 747.
126. McCallum RW., Berkowitz DM., Lerner E Gastric emptying in patients with gastroesophageal reflux Gastroenterology 80 1981 285.
127. Shay SS., Eggli D., McDonald C., Johnson LF Gastric emptying of solid food in patients with gastroesophageal reflux Gastroenterology 92 1987 459.
128. Schwizer W., Hinder RA., DeMeester TR Does delayed gastric emptying contribute to gastroesophageal reflux? Am J Surg 157 1989 74.
129. Carlsson R., Dent J., Bolling-Sternevold E., et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease Scand J Gastroenterol 33 1998 1023.
130. Fass R., Naliboff BD., Fass SS., et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease Gastroenterology 134 2008 696-705.
131. Schey R., Dickman R., Parthasarathy S., et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease Gastroenterology 133 2007 1787-1795.
132. Wright CE., Ebrecht M., Mitchell R., et al. The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux J Psychosom Res 59 2005 415-424.
133. Shaker R., Castell DO., Schoenfeld PS., Spechler SJ Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: The results of a Gallup survey conducted on behalf of the American Gastroenterological Association Am J Gastroenterol 98 2003 1487.
134. Klauser AG., Schindlebeck NE., Muller-Lissner SA Symptoms of gastro-oesophageal reflux disease Lancet 335 1990 205.
135. Dent J., Brun J., Fendrick AM., et al. An evidence-based appraisal of reflux disease management-The Genval report Gut 44 1999 S1.
136. Kahrilas PJ Clinical vignette: refractory heartburn Gastroenterology 124 2003 1941-1945.
137. Tominaga M., Caterina MJ., Malmberg AB., et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli Neuron 21 1998 531-543.
138. Caterina MJ., Julius D The vanilloid receptor: A molecular gateway to the pain pathway Annu Rev Neurosci 24 2001 487-517.
139. Hwang SW., Oh U Hot channels in airways: Pharmacology of the vanilloid receptor Curr Opin Pharmacol 2 2002 235-242.
140. Trevisani M., Smart D., Gunthorpe MJ., et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1 Nat Neurosci 5 2002 546-551.
141. Matthews PJ., Aziz Q., Facer P., et al. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus Eur J Gastroenterol Hepatol 16 2004 897-902.
142. Bredenoord AJ., Weusten BL., Curvers WL., et al. Determinants of perception of heartburn and regurgitation Gut 55 2006 313-318.
143. Tack J Review article: the role of bile and pepsin in the pathophysiology and treatment of gastroesophageal reflux disease Aliment Pharmacol Ther 24 2006 10-16.
144. Tobey NA., Hosseini SS., Caymaz-Bor C., et al. The role of pepsin in acid injury to esophageal epithelium Am J Gastroenterol 96 2001 3062-3070.
145. Balaban D., Yamamoto Y., Liu J., et al. Sustained esophageal contraction: A marker of esophageal chest pain identified by intraluminal ultrasonography Gastroenterology 116 1999 29.
146. Rao SS., Gregersen H., Hayek B., et al. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus Ann Intern Med 124 1996 950-958.
147. Jacob P., Kahrilas PJ., Vanagunos A Peristaltic dysfunction associated with non-obstructive dysphagia in reflux disease Dig Dis Sci 35 1990 939.
148. Brzana RJ., Koch KL Gastroesophageal reflux disease presenting with intractable nausea Ann Intern Med 126 1997 704.
149. Johnson DA., Winters C., Spurling TJ., et al. Esophageal acid sensitivity in Barrett’s esophagus J Clin Gastroenterol 9 1987 23.
150. Extraesophageal presentations of gastroesophageal reflux disease Am J Gastroenterol 25 2000 S1.
151. Schofied PM., Bennett DH., Whorewell PJ., et al. Exertional gastroesophageal reflux: A mechanism for symptoms in patients with angina pectoris and normal coronary angiograms BMJ 294 1987 1459.
152. Hewson EG., Sinclair JW., Dalton CB., et al. Twenty-four hour esophageal pH monitoring: The most useful test for evaluating non-cardiac chest pain Am J Med 90 1991 576.
153. Richter JE Approach to the patient with non-cardiac chest pain In: Yamada T Textbook of gastroenterologyed 2 1995 JB Lippincott Philadelphia 648.
154. Gustafsson U., Tibbling L The effect of edrophonium chloride-induced chest pain on esophageal blood flow and motility Scand J Gastroenterol 32 1997 104-107.
155. Harding SM., Sontag SJ Asthma and gastroesophageal reflux Am J Gastroenterol 95 2000 S23.
156. Liou A., Grubb JR., Schechtman KB., Hamilos DC Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care Chest 124 2003 1781.
157. Irwin RS., Curley FJ., French CL Difficult-to-control asthma: Contributing factors and outcome of a systematic protocol Chest 103 1993 1662.
158. Bortolotti M., Gentilini L., Morselli C., Giovannini M Obstructive sleep apnoea is improved by a prolonged treatment of gastrooesophageal reflux with omeprazole Dig Liver Dis 38 2006 78-81.
159. Tuchman DN., Boyle JT., Pack AI., et al. Comparison of airway responses following tracheal or esophageal acidification in the cat Gastroenterology 87 1984 872.
160. Schan CA., Harding SM., Haile JM., et al. Gastroesophageal reflux-induced bronchoconstriction: An intraesophageal acid infusion study using state-of-the-art technology Chest 105 1994 731.
161. Jack CIA., Calverley PMA., Donnelly RJ., et al. Simultaneous tracheal and oesophageal pH measurements in asthmatics patients with gastro-oesophageal reflux Thorax 50 1995 201.
162. Koufman JA The otolaryngologic manifestations of gastro-esophageal reflux disease: A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury Laryngoscope Suppl 53 1991 1.
163. Wong RKH., Hanson DG., Waring PJ., Shaw G ENT manifestations of gastroesophageal reflux Am J Gastroenterol 95 2000 S15.
164. Adhami T., Goldblum JR., Richter JE., Vaezi MF The role of gastric and duodenal agents in laryngeal injury: An experimental canine model Am J Gastroenterol 99 2004 2098.
165. Jacob P., Kahrilas PH., Herzon G Proximal esophageal pH-manometry in patients with “reflux laryngitis.” Gastroenterology 100 1991 305.
166. Irwin RS., Richter JE Gastroesophageal reflux and cough Am J Gastroenterol 95 2000 S39.
167. Javorkova N., Varechova S., Pecova R., et al. Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough Neurogastroenterol Motil 20 2008 119-124.
168. Chang AB, Lasserson TJ, Gaffney J, et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 2006; 18:CD004823.
169. Lazarchik DA., Filler SJ Dental erosion: Predominant oral lesion in gastroesophageal reflux disease Am J Gastroenterol 95 2000 S33.
170. Richter JE Gastroesophageal reflux disease during pregnancy Gastroenterol Clin North Am 32 2003 235.
171. Zamost BJ., Hirschberg J., Ippoliti AF., et al. Esophagitis in scleroderma: Prevalence and risk factors Gastroenterology 92 1987 421.
172. Miller LS., Vinayek R., Frucht H., et al. Reflux esophagitis in patients with the Zollinger-Ellison syndrome Gastroenterology 98 1990 341.
173. Vaezi MF., Richter JE Current therapies for achalasia: Comparison and efficacy J Clin Gastroenterol 27 1998 21.
174. Nagler R., Spiro HM Persistent gastroesophageal reflux induced during prolonged gastric intubation N Engl J Med 269 1963 495.
175. Richter JE Diagnostic tests for gastroesophageal reflux disease Am J Med Sci 326 2003 300.
176. Schindlebeck NE., Klauser AG., Voderholzer WA., Mueller-Lissner S Empiric therapy for gastroesophageal reflux disease Arch Intern Med 155 1995 1808.
177. Fass R., Ofman JJ., Granelk I., et al. Clinical and economic assessment of the omeprazole test in patients with symptomatic suggestive of gastroesophageal reflux disease Arch Intern Med 159 1999 2161.
178. Fass R., Fennerty MB., Ofman JJ The clinical and economic value of a short course of omeprazole in patients with non-cardiac chest pain Gastroenterology 115 1998 42.
179. Ours TM., Kavuru MS., Schilz R., Richter JE A prospective evaluation of esophageal testing and a double blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough Am J Gastroenterol 94 1999 3131.
180. Richter JE Severe reflux esophagitis Gastrointest Endosc Clin North Am 4 1994 677.
181. Johnson LF., DeMeester TF., Haggitt RC Endoscopic signs of gastroesophageal reflux objectively evaluated Gastrointest Endosc 22 1976 151.
182. Nayer DW., Vaezi MF Classification of esophagitis: Who needs it? Gastrointest Endosc 60 2004 253.
183. Ollyo JB., Lang F., Fontolliet C., Monnier P Savary-Miller’s new endoscopic grading of reflux-oesophagitis: A simple, reproducible, logical, complete and useful classification Gastroenterology 98 1990 A100.
184. Lundell LR., Dent J., Bennett JR., et al. Endoscopic assessment of oesophagitis: Clinical and functional correlation and further validation of the Los Angeles classification Gut 45 1999 172.
185. Sharma P., Wani S., Rastogi A., et al. The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett’s esophagus: A blinded, prospective study Am J Gastroenterol 103 2008 525-532.
186. DeVault KR., Castell DO Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease Am J Gastroenterol 100 2005 190.
187. Dent J Microscopic esophageal mucosal injury in nonerosive reflux disease Clin Gastroenterol Hepatol 5 2007 4-16.
188. Funch-Jensen P., Kock K., Christensen LA., et al. Microscopic appearance of the esophageal mucosa in a consecutive series of patients submitted to endoscopy: Correlation with gastroesophageal reflux symptoms and microscopic findings Scand J Gastroenterol 21 1986 65.
189. Riddell RH The biopsy diagnosis of gastroesophageal reflux disease, “carditis, " and Barrett’s esophagus Am J Surg Pathol 20 1996 31.
190. Schindlbeck NE., Wiebecke B., Kaluser AG., et al. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease Gut 39 1996 151.
191. Hirano I., Richter JE ACG practice guidelines: Esophageal reflux testing Am J Gastroenterol 102 2007 668-685.
192. Booth MI., Stratford J., Dehn TCB Patient self-assessment of test-day symptoms in 24 hour pH metry for suspected gastroesophageal reflux disease Scand J Gastroenterol 36 2001 795.
193. Weusten BLAM., Snout AJPM Symptom analysis in 24-hour esophageal pH monitoring In: Richter JE Ambulatory esophageal pH monitoring: Practical approach and clinical application2nd ed 1997 Williams & Wilkins Baltimore 97.
194. Wenner J., Johnsson F., Johansson J., Oberg S Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial Am J Gastroenterol 102 2007 239-245.
195. Zerbib F., des Varannes SB., Roman S., et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects Aliment Pharmacol Ther 22 2005 1011-1021.
196. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring Gut 55 2006 1398-1402.
197. Zerbib F., Roman S., Ropert A., et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy Am J Gastroenterol 101 2006 1956-1963.
198. Ott DJ., Kelley TF., Chen MYM., et al. Use of a marshmallow bolus for evaluating lower esophageal mucosal rings Am J Gastroenterol 86 1991 817.
199. Ott DJ Gastroesophageal reflux disease Radiol Clin North Am 32 1994 1147.
200. Thompson JK., Koehler RE., Richter JE Detection of gastro-esophageal reflux: Value of the barium studies compared with 24-hour pH monitoring Am J Roentgenol 162 1994 621.
201. Johnston BT., Troshinsky MB., Castell JA., Castell DO Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease Am J Gastroenterol 91 1996 1181.
202. Waring JP., Hunter JG., Oddsdottir M The preoperative evaluation of patients considered for laparoscopic antireflux surgery Am J Gastroenterol 90 1995 35.
203. Leite LP., Johnston BT., Barrett J., et al. Ineffective esophageal motility: The primary finding in patients with non-specific esophageal motility disorder Dig Dis Sci 42 1997 1853.
204. Oleynikov D., Eubanks TR., Oelschlager BK., Pellegrini CA Total fundoplication is the operation of choice for patients with gastroesophageal reflux and defective peristalsis Surg Endosc 16 2002 909.
205. Tutuian R., Castell DO Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: Studies using combined impedance-manometry Gastroenterology 2 2004 230.
206. Pace F., Santalucia F., Bianchi-Porro G Natural history of gastroesophageal reflux disease without esophagitis Gut 32 1991 845.
207. Isolauri J., Luostarinen M., Isolauri E., et al. Natural history of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients Am J Gastroenterol 92 1997 37.
208. Labenz J., Nocon M., Lind T., et al. Prospective follow-up data from the PROGERD study suggest that GERD is not a categorical disease Am J Gastroenterol 101 2006 2457-2462.
209. Sontag SJ., Sonnenberg A., Schnell TG., et al. The long-term natural history of gastroesophageal reflux disease J. Clin Gastroenterol 40 2006 398-404.
210. Winters C., Spurling TJ., Chobanian SJ., et al. Barrett’s esophagus: A prevalent, occult complication of gastroesophageal reflux disease Gastroenterology 92 1987 118.
211. Lind T., Havelund T., Carlsson R., et al. Heartburn without oesophagitis: Efficacy of omeprazole therapy and features determining therapeutic response Scand J Gastroenterol 32 1997 974.
212. Jones RH., Hungin ADS., Phillips J., et al. Gastroesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings Eur J Gen Pract 1 1995 149.
213. Robinson M., Earnest D., Rodriguez-Stanley S., et al. Heartburn requiring frequent antacid use may indicate significant illness Arch Intern Med 156 1998 2373.
214. Wu JC., Chenng CMY., Wong VWS., Sung JJY Distinct clinical characteristics between patients with non-erosive reflux disease and those with reflux esophagitis Clinical Gastroenterology and Hepatology 5 2007 690-695.
215. Fass R Erosive esophagitis and non-erosive reflux disease. Comparison of epidemiologic, physiologic and therapeutic characteristics J Clin Gastroenterol 41 2007 131-137.
216. Trimble KC., Douglas S., Pryde A., Heading RC Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux Dig Dis Sci 40 1995 1098.
217. Hetzel DJ., Dent J., Reed WD., et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole Gastroenterology 95 1988 903.
218. Vigneri S., Termini R., Leandro G., et al. A comparison of five maintenance therapies for reflux esophagitis N Engl J Med 333 1995 1106.
219. Spechler SJ Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans N Engl J Med 326 1992 786.
220. Rantanen TK., Silvio EI., Rasanen JV., Salo JA Gastroesophageal reflux as a cause of death is increasing: Analysis of total cases after medical and surgical treatment Am J Gastroenterol 102 2007 246-253.
221. Higuchi D., Sagawa C., Shab SH., et al. Etiology, treatment and outcome of esophageal ulcers: A 10 year experience in an urban emergency hospital J Gastrointest Surg 7 2003 836.
222. DaCosta N., Guillaume C., Merle C., et al. Bleeding reflux esophagitis: A prospective 1-year study in a university hospital Am J Gastroenterol 96 2001 47.
223. Richter JE Peptic strictures of the esophagus Gastroenterol Clin North Am 28 1999 875.
224. El-Serag HB., Sonnenberg A Association of esophagitis and esophageal strictures with diseases treated with non-steroidal anti-inflammatory drugs Am J Gastroenterol 92 1997 52.
225. Marshall JB., Kretschman JM., Kiaz-Arias AA Gastro-esophageal reflux as a pathogenic factor in the development of symptomatic lower esophageal rings Arch Intern Med 150 1990 1669.
226. Kaltenback T., Crockett S., Gerson LB Are lifestyle measures effective in patients with gastroesophageal reflux disease? Am J Gastroenterol 101 2006 2128-2138.
227. Meining A., Classen M The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease Am J Gastroenterol 95 2000 2692.
228. Feldman M., Barnett C Relationship between the acidity and osmolality of popular beverages and reported postprandial heartburn Gastroenterology 108 1995 125.
229. Weberg R., Berstad A Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis Scand J Gastroenterol 24 1989 401.
230. Buts JP., Barudi C., Otte JB Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24h continuous pH monitoring in infants and children Eur J Pediatr 146 1987 156.
231. Behar J., Sheahan DG., Biancani P., et al. Medical and surgical management of reflux esophagitis: A 38-month report on a prospective clinical trial N Engl J Med 293 1975 263.
232. Lieberman DA Medical therapy for chronic reflux esophagitis: Long term follow-up Arch Intern Med 147 1987 717.
233. Gonzalez ER., Grillo JA Over-the-counter histamine2-blocker therapy Ann Pharmacother 28 1994 392.
234. Fendrick AM., Shaw M., Schachtel B., et al. Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn Clin Gastroenterol Hepatol 2 2004 17.
235. Ramirez B., Richter JE Review article: Promotility drugs in the treatment of gastro-oesophageal reflux disease Aliment Pharmacol Ther 7 1993 5.
236. Wysowski DK., Corken A., Gallo-Torres H., et al. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory action Am J Gastroenterol 96 2001 1698.
237. Richter JE New investigational therapies for gastroesophageal reflux disease Thorac Surg Clin 15 2005 377-384.
238. Ciccaglione AF., Marzio I Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH-metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease Gut 52 2003 464.
239. Koek GH., Sifrim D., Lerut T., et al. Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastroesophageal reflux refractory to proton pump inhibitors Gut 52 2003 1397.
240. Lipsy RJ., Fennerty B., Fagan TC Clinical review of histamine -2 receptor antagonists Arch Intern Med 150 1990 745.
241. Sontag SJ Gastroesophageal reflux disease In: Brandt LJ Clinical practice of gastroenterology 1999 Churchill Livingstone Philadelphia 21.
242. Chiba N., Gara CJ., Wilkinson JM., Hunt RH Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis Gastroenterology 112 1997 1798.
243. Peghini PL., Katz PO., Castell DO Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects Gastroenterology 115 1998 1335.
244. Wilder-Smith CH., Merki HS Tolerance during dosing with H2-receptor antagonists: An overview Scand J Gastroenterol 27 1992 14.
245. Fackler WK., Ours TM., Vaezi MF., Richter JE Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough Gastroenterology 122 2002 625.
246. Klinkenberg-Knol EC., Festen HPM., Meuwissen SGM Pharmacological management of gastro-oesophageal reflux disease Drugs 49 1995 697.
247. Wolfe MM., Sachs G Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome Gastroenterology 118 2000 9.
248. Hunt RH Importance of pH control in the management of GERD Arch Intern Med 159 1999 649.
249. Miner P., Katz PO., Chen Y., Sostek M Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole: A five-way crossover study Am J Gastroenterol 98 2003 2616.
250. vanPinxteren B, Numans ME, Bonis PA, Lau J. Short term treatment with proton pump inhibitors, H2RAs and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004; 3:CD002095.
251. Sontag SJ., Hirschowitz BH., Holt S., et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study Gastroenterology 102 1992 109.
252. Castell DO., Richter JE., Robinson M., et al. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis Am J Gastroenterol 91 1996 1749.
253. Cloud ML., Enas N., Humphries TJ., et al. Rabeprazole in treatment of acid peptic diseases Dig Dis Sci 43 1998 993.
254. Richter JE., Bochenek W., Pantoprazole US GERD Study Group Oral pantoprazole for erosive esophagitis: A placebo-controlled, randomized clinical trial Am J Gastroenterol 95 2000 3071.
255. Moayyedi P., Talley N Gastroesophageal reflux disease Lancet 367 2006 2086-2100.
256. Bianchi Porro G., Pace F., Peracchia A., et al. Short-term management of refractory reflux esophagitis with different doses of omeprazole or ranitidine J Clin Gastroenterol 15 1992 192.
257. Richter JE., Kahrilas PJ., Johanson J., et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial Am J Gastroenterol 96 2001 656.
258. Castell DO., Kahrilas PJ., Richter JE., et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis Am J Gastroenterol 97 2002 575.
259. Gralnek IM., Dulai GS., Fennerty MB., Speigel BMR Esomeprazole versus other PPIs in erosive esophagitis: A meta-analysis of randomized clinical trials Clin Gastroenterol Hepatol 4 2006 1452-1458.
260. Metz D., Pratha V., Martin P., et al. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with GERD Am J Gastroenterol 95 2000 626.
261. Garnett WR Consideration for long-term use of proton pump inhibitors Am J Health Syst Pharm 55 1998 2269.
262. Toussaint J., Gossuin A., Deruyttere M., et al. Healing and prevention of relapse of reflux esophagitis by cisapride Gut 35 1991 590.
263. Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux esophagitis. Cochrane Database Syst Rev 2004; 3:CD003245.
264. Klinkenberg-Knol EC., Nelis F., Dent J., et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa Gastroenterology 118 2000 661.
265. Inadomi JM., Jamal R., Murata GH., et al. Step-down management of gastroesophageal reflux disease Gastroenterology 121 2001 1095.
266. Inadomi JM., McIntyre L., Bernard L., Fendrick AM Step-down from multiple-to-single dose PPIs: A prospective study of patients with heartburn or acid regurgitation relieved by PPIs Am J Gastroenterol 98 2003 1940.
267. Freston JW Omeprazole, hypergastrinemia and gastric carcinoid tumors Ann Intern Med 121 1994 232.
268. Singh M., Dhindsa G., Friedland S., Triadafilopoulos G Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas Aliment Pharmacol Ther 26 2007 1051-1061.
269. Jalving M., Koornstra JJ., Wesseling J., et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy Aliment Pharmacol Ther 24 2006 1341-1348.
270. Laheij RJF., Sturkenboom MCJM., Hassing RJ., et al. Risk of community-acquired pneumonia and use of gastric acid-suppression drugs JAMA 292 2004 1955-1960.
271. Leonard J., Marshall JK., Moayyedi P Systematic review of the risk of enteric infections in patients taking acid suppression Am J Gastroenterol 102 2007 2047-2056.
272. Yang YX., Lewis JD., Epstein S., Metz DC Longterm proton pump inhibitor therapy and risk of hip fracture JAMA 296 2006 2947-2953.
273. Targownik LE., Lix LM., Metge CJ., et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures CMAJ 179 2008 319-326.
274. Howden CW., Coté GA Potential adverse effects of proton pump inhibitors Current Gastroenterology Reports 10 2008 208-214.
275. Kuipers E., Lundell L., Klinkenberg-Knol EC., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication N Engl J Med 334 1996 1018.
276. Proton pump inhibitors relabeling for cancer risk not warranted. FDA report, November 11, 1996.
277. Ireland AC., Holloway RH., Toouli J., Dent J Mechanisms underlying the antireflux action of fundoplication Gut 34 1993 303.
278. Rice TW Why antireflux surgery fails Digest Dis 18 2000 43.
279. Oelschlager BK., Eubanks TR., Pellegrini CA Hiatal hernia and gastroesophageal reflux disease In: Townsend CM., Beauchamp RD., Foshee JC., et al. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice18th ed 2007 Saunders.
280. Watson DI Laparoscopic treatment of gastro-oesophageal reflux disease Best Pract Res Clin Gastroenterol 18 2004 19-35.
281. Horvath KD., Jobe BA., Herron DM., Swanstrom LL Laparoscopic Toupet fundoplication is an inadequate procedure for patients with severe reflux disease J Gastrointest Surg 3 1999 583.
282. Gastal OL., Hagen JA., Peters JH Short esophagus: Analysis of predictors and clinical implications Arch Surg 134 1999 633.
283. Fink JF., Wei Y., Birkmeyer JD The rise and fall of antireflux surgery in the United States Surg Endosc 20 2006 1698-1701.
284. Dominitz JA., Dire CA., Billingsley KG., Todd-Stenberg JA Complications and anti-reflux medication use after antireflux surgery Clin Gastroenterol Hepatol 4 2006 299-305.
285. Allgood PC., Bachmann M Medical or surgical treatment for chronic gastroesophageal reflux? A systematic review of the published evidence of effectiveness Eur J Surg 166 2000 713-721.
286. So JBY., Zeitel SM., Rattner DW Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication Surgery 124 1998 28.
287. Perdikis G., Hinder RA., Lund RJ., et al. Laparoscopic Nissen fundoplication: Where do we stand? Surg Laparosc Endosc 7 1997 17.
288. Corey KE., Schmitz SM., Shaheen NJ Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett’s esophagus? A meta-analysis Am J Gastroenterol 98 2003 2390-2394.
289. Lundell L., Miettinen P., Myrvold HE., et al. Continued (5-year) follow-up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease J Am Coll Surg 192 2001 172.
290. Vakil N., Shaw M., Kirby R Clinical effectiveness of laparoscopic fundoplication in a U.S. community Am J Med 114 2003 1.
291. Spechler SJ., Lee EL., Ahnen D., et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial JAMA 285 2001 2331.
292. Oelschlager BK., Quiroga E., Parras JD., et al. Long-term outcomes from laparoscopic antireflux surgery Am J Gastroenterol 103 2008 280-287.
293. Hatch KF., Daily MF., Christiansen BJ., Glasgow RE Failed fundoplication Am J Surg 188 2004 786-791.
294. Kahrilas PJ Radiofrequency therapy for the lower esophageal sphincter for treatment of GERD Gastrointest Endosc 57 2003 723.
295. Fennerty MB Endoscopic suturing for treatment of GERD Gastrointest Endosc 57 2003 390.
296. Edmundowicz SA Injection therapy of the lower esophageal sphincter for the treatment of GERD Gastrointest Endosc 59 2004 545.
297. Corley DA., Katz P., Wo JM., et al. Improvement of gastro-esophageal reflux symptoms after radiofrequency energy: A randomized, sham-controlled trial Gastroenterology 125 2003 668.
298. Rothstein R., Filipi C., Caca K., et al. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial Gastroenterology 131 2006 704-712.
299. Falk GW., Fennerty MB., Rothstein RI AGA Institute technical review on the use of endoscopic therapy for gastroesophageal reflux disease Gastroenterology 131 2006 1351-1366.
300. Cremmini F., Wise J., Moayyedi P., Talley N Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: A meta-analysis Am J Gastroenterol 100 2005 1226-1232.
301. Wang WH., Huang JQ., Zheng GK., et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with non-cardiac chest pain? A meta-analysis Arch Intern Med 165 2005 1222-1228.
302. Chang AB, Lasserson TJ, Gaffney J, et al. Gastroesophageal reflux disease for prolonged non-specific cough in children and adults. Cochrane Database Systemic Review 2005;2:CD004823.
303. American Lung Association Asthma Clinical Research Centers., Mastronarde JG., Anthonisen NR., et al. Efficacy of esomeprazole for treatment of poorly controlled asthma N Engl J Med 360 2009 1487-1499.
304. Qadeer MA., Philips CO., Lopez AR., et al. Proton pump inhibitor therapy suspected GERD-related chronic laryngitis: A meta-analysis of randomized controlled trials Am J Gastroenterol 101 2006 2646-2654.
305. Johnson DA., Orr WC., Crawley JA., et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: A randomized, placebo-controlled trial Am J Gastroenterol 100 2005 1914-1922.
306. Dakkak M., Hoare RC., Maslin SC., et al. Oesophagitis is as important as oesophageal stricture diameter in determining dysphagia Gut 34 1993 152.
307. Riley SA., Attwood SEA Guidelines on the use of oesophageal dilatation in clinical practice Gut 55 2004 1.
308. Marks RD., Richter JE., Rizzo J., et al. Omeprazole vs H2RAs in treating patients with peptic stricture and esophagitis Gastroenterology 106 1994 907.
309. Guda NM., Vakil N Proton pump inhibitors and the time trends for esophageal dilation Am J Gastroenterol 99 2004 797.
310. Sgouros SN., Vlachogiannakos J., Karamanolis G., et al. Long-term acid suppression therapy may prevent the relapse of lower esophageal (Schatzki’s) rings: A prospective, randomized, placebo-controlled study Am J Gastroenterol 100 2005 1929-1933.